Use of peptides of general formula I X-SEQ ID No.1-Y in the...

Details Use of peptides of general formula I X-SEQ ID No.1-Y in the... Use of peptides of general formula I X-SEQ ID No.1-Y in the...

2011-05-17

2011-05-17

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Cosmetic, antiperspirant, dentifrice

C514S018600, C514S018800, C514S021800

Reexamination Certificate

active

07943156

ABSTRACT:
The invention relates to cosmetic compositions which are intended to improve the firmness of the skin by increasing adhesion of cutaneous cells in relation to one another and the basal lamina. The aforementioned compositions comprise a cosmetically-effective quantity of peptides having general formula X-isoleucyl-lysyl-valyl-alanyl-valine-Y, known as X-SEQ ID No. 1-Y (FIG.1). The invention also relates to the use of X-SEQ ID No. 1-Y peptides in the preparation of cosmetic compositions which are intended to improve the firmness of the skin.

REFERENCES:
patent: 5744515 (1998-04-01), Clapper
patent: 6428579 (2002-08-01), Valentini
patent: 6673108 (2004-01-01), Zilla et al.
patent: 1325739 (2003-07-01), None
patent: 3197411 (1991-08-01), None
patent: 2002-45419 (2002-02-01), None
patent: WO 98/43686 (1998-10-01), None
patent: WO 03/007905 (2003-01-01), None
Grant et al. Revascularization of Ischemic Tissues with SIKVAV and Neuropeptide Y (NPY). 2000. Angiogenesis: From the Molecular to Integrative Pharmacology, pp. 139-154.
Machine Translation of JP 2002-45419 (Feb. 12, 2002).
Translation of Japanese Patent Application 2002-45419, published Feb. 12, 2002, titled “Wound Coating Material”.
Almiñana-Domenech, N. et al. “Synthesis, interaction with phospholipids and biological activity of the laminin active sequence: SIKVAV.” Journal of Peptide Science, 2002, vol. 8, p. S146 © 2002 European Peptide Society and John Wiley & Sons, Inc.
LeVarlet, B. et al., “Age-Related Functional and Structural Changes in Human Dermo-Epidermal Junction Components.” LVMH Recherche, Parfums Christian Dior, Symposium Proceedings, Journal for Investigative Dermatology 1998, pp. 172-179.
Grant, D.S., et al.,“Interaction of Endothelial Cells With a Laminin A Chain Peptide (SIKVAV) In Vitro and Induction of Angiogenic Behavior in Vivo.” Journal of Cellular Physiology 153:614-625 © 1992 Wiley-Liss Inc.

Affiliated with

Also associated with

Rating

Use of peptides of general formula I X-SEQ ID No.1-Y in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of peptides of general formula I X-SEQ ID No.1-Y in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peptides of general formula I X-SEQ ID No.1-Y in the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2645310